Intestinal barrier immaturity, or "leaky gut," is the proximate cause of susceptibility to 20 necrotizing enterocolitis in preterm neonates. However, the impact of intestinal 21 microbiota development on intestinal mucosal barrier maturation has not been 22 evaluated in this population. In this study, we investigated a longitudinally sampled 23 cohort of 38 preterm infants monitored for intestinal permeability (IP) and fecal 24 microbiota during the first two weeks of life. Rapid decrease in IP indicating intestinal 25 barrier function maturation correlated with significant increase in community diversity. In 26 particular, members of the Clostridiales and Bifidobacterium were highly 27 transcriptionally active, and progressively increasing abundance in Clostridiales was 28 significantly associated with decreased gut permeability. Further, neonatal factors 29 previously identified to promote intestinal barrier maturation, including early exclusive 30 breastmilk feeding and low antibiotic exposure, favor the early colonization of the gut 31 microbiota by members of the Clostridiales, which altogether are associated with 32 improved intestinal barrier function in preterm infants. 33 affecting approximately 7-10% of preterm neonates with mortality as high as 30-50% 13 . 57
Introduction 34
The intestinal mucosa paracellular trafficking of macromolecules is controlled by a 35 competent epithelial barrier 1 . The intestinal barrier constitutes a protective shield to the 36 diffusion of pathogens and other elements with pro-inflammatory and tissue injury 37
properties, and regulates absorption and secretion of essential nutrients 2 . A functional 38 intestinal barrier is driven by a complex structure that includes physical barrier with 39 coinciding chemical, immunological and microbiological components 3 . The colonization 40 with microorganisms starts at birth and undergoes rapid shifts in composition and 41 structure as the host matures over time 4 . These microorganisms perform essential 42 functions mechanistically linked to intestinal barrier competency, including epithelial 43 metabolism, proliferation and survival, mucin and antimicrobial compound production, 44 and cell-cell communication signaling molecule secretion 3 . The microbial community in 45 general is considered to play critical roles in the early development of the intestinal 46 epithelium, the immune system, nutrient acquisition and energy regulation, and 47 opportunistic pathogens suppression 3, 5 . 48 49 Disrupting intestinal microbiota, on the other hand, leads to dysbiosis, a state of 50 ecological imbalance where the community loses diversity, key bacterial species, and 51 more critically metabolic capacity with reduced colonization resistance to opportunistic 52 pathogens 6 . Early life gut dysbiosis is associated with disease susceptibility along with 53 short-term and lifelong health issues, such as necrotizing enterocolitis (NEC) 7 , sepsis 7 , 54 asthma and allergies 8 , type 1 diabetes 9 , celiac disease 10 , inflammatory bowel disease 55 abundance from study day 1 to day 8, and ~16% median and ~45% maximal relative 145 abundance again from study day 8 to 15; (3) on the other hand, in samples measured in 146 high IP at study day 1 that are also high at the follow up days, members of Clostridiales 147 was almost completely absent on study day 8 and no increase was observed from study 148 day 1 to 8, and the increase from study 8 to 15 was small at ~3% median and ~10% 149 maximal relative abundance; (4) in infants 6-24 months old, Clostridiales is the most 150 abundant taxonomic groups with >50% median and >85% maximal relative abundance 151 (Supplemental Figure 4) . Together, our results suggest preterm infants at birth have 152 low abundance of Clostridiales, which became progressively and significantly more 153 abundant only in the group with rapid progression of intestinal barrier maturation, while 154 remained low in those with persistent high IP over the first two weeks of life. 9 
156
We further calculated the predictive power of microbiota composition in classifying IP 157 using random forest supervised machine learning scheme. The top 15 phylotypes with 158 the highest mean decrease gini index importance measure (Supplemental Figure 5 ) 159 were used to fit a random effect logistic regression model of IP, 4 of which resulted 160 significantly associated with low IP (Supplemental File 5), including three members of 161 the order Clostridiales, Coprococcus (p-value = 0.004), Lachnospiraceae (p-value = 162 0.007), Veillonella dispar (p-value = 0.01), and Bifidobacterium (p-value = 0.01) from the 163 order of Bifidobacteriales. Interestingly, Bifidobacteriales was the second most 164 abundant taxonomic groups in infants 6-24 months old, only lower than Clostridiales 165 (Supplemental Figure 4) . 166
Clostridiales and Bifidobacterium are highly active members of the intestinal microbiome 167
The level of bacterial transcriptional activities was characterized by studying the suite of 168 genes present and expressed in preterm infant intestinal microbiota. A total of 869 169 million metagenomic sequence reads (average of ~31.0 million sequence reads per 170 sample) and 694 million metatranscriptomic sequence reads (average of ~53.4 million 171 sequence reads per sample) were obtained after quality assessment. Figure 4 shows 172 that Bifidobacterium breve (Actinobacteria), Veillonella and Clostridiales Family XI 173 incerteae Sedis (Clostridiales) are the most transcriptionally active bacteria with high 174 ratio of transcript abundances over gene abundances in all samples. Further, the levels 175 of transcriptional activities of Bifidobacterium breve and Clostridiales Family XI 176 incerteae Sedis are correlated with a spearman correlation of 0.89, suggesting these 1 0
Figure 6). We observed increased abundance of both Clostridiales and 179
Bifidobacteriales through the transition from the first two weeks (phase I) to later age of 180 A critical value of understanding the driver of IP, including associated microbiological 275 biomarkers, is in its clinical significance in NEC risk diagnostics and disease prevention. 276
The etiology of NEC involves the interaction between immature intestinal barrier and the 277 developing intestinal microbial community that leads to an excessive inflammatory 278 response 25, 26, 28, 29 . Though IP is high at birth in preterm infants, it rapidly decreases over 279 the first few days, which is associated with diminished risks for adverse outcomes 16, 30 . 280
Aberrant intestinal barrier function manifests by persistently high and/or late decrease in 281 IP and is likely due to the physiological immaturity of the GI tract barrier function and 282 altered levels of the normal microbial communities 14, 15 , resulting in microbial invasion of 283 the intestinal wall and gut lamina propria triggering a cascading inflammatory response 284 and ultimately intestinal necrosis and severe infection 2 . Multiple studies have revealed 285 microbial community dysbiosis is involved in stimulating a hyperinflammatory response 286 that leads to NEC 25, 26, 28, 29 . This community dysbiosis has been characterized by the 287 presence of members of the family Enterobacteriaceae such as E. coli, K. pneumonia, 288 as well as Enterobacter cloacae 23, 26, 31 . However, a generalized bacterial dysbiosis 289 alone does not adequately explain NEC. Many preterm infants that are colonized by 290 high abundance of Enterobacteriaceae do not develop NEC 32 , and many NEC cases 291 lacked intestinal colonization of Enterobacteriaceae 33 . In this study, Enterobacteriaceae 292 was significantly associated with both elevated IP and later attainment of full exclusive 293 breastmilk feeding (>10 days), while other beneficial bacteria such as members of 294
Clostridiales and Bifidobacterium were significantly associated with improved IP and 295 earlier breastmilk feeding attainment. These results emphasize the importance of a 296 holistic understanding of the etiology of NEC, including the mechanistic characterization 1 6 of the functional synergy and/or competition among different bacterial groups, as well as 298 nutritional factors, drug uses and host genetics. Further, the links established by 299 previous microbiota association studies could not elucidate the causalities between gut 300 microbiota and NEC development. Our study prospectively associates maturation of gut 301 barrier function with specific microbial community composition and structure for the first 302 time, prior to the onset of NEC. Research on neonatal IP will not only further our 303 understanding of NEC etiology but will help identify the "window of opportunity" for 304 intervention prior to the onset of NEC. Early prediction and prevention of NEC will 305 ultimately improve overall infant survival rates. 306
307
Multiple intrinsic and extrinsic factors affect newborn intestinal microbiota, such as 308 maternal diet, delivery mode, breast milk feeding, antibiotic exposure, and other early 309 life environmental exposures 7,34 . In this study, early exclusive breast milk feeding and 310
low antibiotic exposure was associated with the presence of members of Clostridiales in 311 the stool microbiota of preterm infants. We have previously observed these two factors 312 are associated with improved IP in preterm infants 16 , which has been shown to be 313 critically protective against NEC 35 . This observation emphasizes the importance of 314 factors such as clinical administration of nutritional supplement and limiting exposure to 315 antibiotic in neonatal care units. Interestingly, Clostridiales strains were recently shown 316 to be sensitive to many antibiotics, including ampicillin and amoxicillin 36 , both 317 commonly used for the neonate clinical management. Further understanding of the 318 selective nutritional requirement that favor the growth of these bacteria would afford the 319 development of novel nutritional supplemental strategies to limit the incidence of NEC 320 and improve clinical outcomes in preterm infants. 321 322 Current therapies for NEC are mostly ineffective, and involve antibiotic treatment and 323 surgical interventions, including drain placement or bowel resection. These procedures 324 are associated with poor prognosis and a mortality rate of ~50% due to the rapid 325 progression of the disease 37 . Live biotherapeutics products (LBP) are being considered, 326 but selecting the appropriate one remains a major challenge. LBP therapies are 327 promising, low-cost, and constitute a likely safe preventive measure to improve 328
intestinal barrier maturation and reduce NEC incidence in at-risk preterm infants 38 . In 329 an experimental mouse model of NEC, the administration of Bifidobacterium infantis 330 prevented an increase in IP, stabilized tight junction proteins, and reduced NEC 331 incidence 28 . Translating these findings in human has been challenging. There have 332 been at least 11 randomized controlled trials and a recent meta-analysis of LBP 333 supplementation to prevent NEC in preterm neonates 39 . Although there was a 30% 334 reduction in NEC incidence in these trials, various formulations, doses, and duration of 335 therapy were used, infants <1000 g BW with the highest NEC incidence were under-336
represented, and no Food and Drug Administration-approved products are available to 337 assure quality and safety under good manufacturing practices. Clostridiales revealed their ability to induce regulatory T cells and a protection against 358 colitis and allergic responses 45 . Seventeen strains of human-derived Clostridiales 359 species were rationally selected using gnotobiotic mice and the cocktail shown to have 360 prophylactic effect in mouse colitis 36, 46 . In addition, the administration of Clostridiales 361 protects the host from pathogen infection and abrogated intestinal pathology 47 . In term 362 infants, the presence of Clostridiales in the intestinal microbiota was demonstrated to 363 prevent colonization by bacterial pathogens such as S. Typhimurium 48 . Unfortunately, 364
the current standard application of 16S rRNA V4 or V3-V4 amplicon sequencing is not 1 9 capable to resolve the species of Clostridiales present in a sample 49 . Future taxonomic 366 and functional characterization of Clostridiales species will greatly improve our 367 capability to develop novel diagnostic and treatment strategies, and potentially prevent 368 microbial community-mediated intestinal dysbiosis in preterm infants to optimize 369 intestinal maturation and limit the burden of prematurity 23 . 370
Methods and Materials 371
Participants and intestinal permeability measurement 372
The institutional review boards of the University of Maryland and Mercy Medical Center 373 approved the study protocol and informed consent was obtained from parents for 374 participation of their infants in the study. All methods were performed in accordance with 375 the relevant guidelines and regulations. Thirty-eight preterm infants 24 0/7 -32 6/7 weeks 376 GA were enrolled within 4 days after birth and received 1 ml/kg of the non-metabolized 377 sugar probes lactulose (La) (marker of intestinal paracellular transport)/rhamnose (Rh) 378 (marker of intestinal transcellular transport) (8.6 g La +140 mg Rh/100 mL) enterally on 379 study days 1, 8 ± 2 and 15 ± 2. La/Rh was measured by high-pressure liquid 380 chromatography (HPLC) in urine collected over a 4h period following administration of 381 the sugar probes as previously described 16 . High or low intestinal permeability was 382 defined by a La/Rh >0.05 or <=0.05 respectively, as validated and applied previously 16 . 383
PMA was calculated as gestational age at birth plus week of life as defined previously 50 . 384
Fecal samples (~1g) were collected at the same time, stored immediately in 2 ml of 385
RNAlater (QIAGEN). Urine and fecal samples were archived at -80°C until processed. A 386 standard feeding protocol was used for all preterm participants. To compare microbiota 387 of infants at different growth phases 17,19 , 16 samples from older term infants at phase 388 II/III (6-24 months old) from a previous study 51 were included in the comparative 389 analyses. 390 1
Stool nucleic acid extraction and sequencing 391
DNA was extracted from all samples as previously reported 52 . Briefly, a 500 µl aliquot 392 of fecal material mixture was homogenized and carefully washed twice in PBS buffer. 393
Enzymatic lysis using mutanolysin, lysostaphin and lysozyme was performed, followed 394 by proteinase K, SDS treatment and bead beating. DNA purification from lysates was 395 done on a QIAsymphony automated platform. PCR amplification of the V3-V4 variable 396 region of 16S rRNA gene was performed using dual-barcoded universal primers 319F 397 and 806R as previously described 53 . High-throughput sequencing of the amplicons was 398 performed on an Illumina MiSeq platform using the 300 bp paired-end protocol. 399
Metagenomic sequencing libraries were constructed from the same DNA using Illumina 400
Nextera XT kit according to the manufacturer recommendations. 401
402
Total RNA was extracted from 250 µl of stool homogenized in RNALater. Briefly, lysis 403 was performed by bead beating using the FastPrep lysing matrix B protocol (MP 404 Biomedicals), followed with two rounds of protein cleanup using phenol-chloroform in 405 5PRIME heavy phase lock tubes (QuantaBio) and precipitation of total nucleic acids 406 using isopropanol. Genomic DNA was removed using TURBO DNase (Ambion). 407
Ribosomal RNAs were depleted using the Gram-negative and Human/mouse/rat Ribo-408
Zero rRNA Removal kits (Epicentre Technologies). The resulting RNA was used for 409 library construction using Illumina TruSeq stranded mRNA library preparation kit 410 according to the manufacturer's recommendations. Quantification of the constructed 411 RNA libraries was performed on an Agilent Bioanalyzer using the DNA 1000 Nano kit. 412
HiSeq 4000 instrument at the Genomics Resource Center (GRC), Institute for Genome 414
Sciences, University of Maryland School of Medicine using the 150 bp paired-end 415 protocol. 416
Bioinformatics analysis of intestinal microbiota 417
Sequencing read quality assessment was performed using strict criteria to ensure high 418 quality and complete sequences of the amplified the V3-V4 regions of the 16S rRNA 419 gene, according to the procedures, programs and citations, and parameters described 420 previously 53 . Briefly, a sequence read was trimmed at the beginning of a 4 bp sliding 421 window if the average quality score was less than Q15. The sequence read was then 422 assessed for length and retained if it was at least 75% of its original length. The paired-423 end reads were assembled to take advantage of the ~90bp overlapping region. These 424 sequences were further de-multiplexed the sequence reads by individual samples. 425
Additional quality filtering was applied that removed sequences with more than one 426 mismatch in the barcode sequence tag or with ambiguous nucleotide. Taxonomic 427 assignments were performed on each sequence using the Ribosomal Database Project 428 trained on the Greengene database (Aug 2013 version), using 0.8 confidence values as 429 cutoff. Clustering taxonomic profiles was performed as previously described 52 . The 430 number of clusters was validated using gap statistics implemented in the cluster 431 package in R 54 by calculating the goodness of clustering measure. Within-sample 432 diversity was estimated using both observed OTUs to measure community richness and 433
Shannon diversity index. Linear discriminant analysis (LDA) effect size (LEfSe) analysis 434 value for the non-parametric factorial Kruskal-Wallis (KW) sum-rank test was set at 0.05 437 and the threshold for the logarithmic LDA model 56 score for discriminative features was 438 set at 2.0. An all-against-all BLAST search in multi-class analysis was performed. 439
Balance tree analysis was applied as implemented in Gneiss, and trees were generated 440 using Ward hierarchical clustering of abundance profiles. Balance was computed as the 441 isometric log ratio of mean abundances at each bifurcating node in the tree, to 442 
Intestinal microbiome analyses 477
Metagenomic and metatranscriptomic sequence data were pre-processed using the 478 following steps: 1) human sequence reads and rRNA LSU/SSU reads were removed 479 using BMTagger v3.101 60 using a standard human genome reference (GRCh37.p5) 61 ; 480
2) rRNA sequence reads were removed in silico by aligning all reads using Bowtie v1 62 481 to the SILVA PARC ribosomal-subunit sequence database 63 . Sequence read pairs were removed even if only one of the reads matched to the human genome reference or 483 to rRNA; 3) the Illumina adapter was trimmed using Trimmomatic 64 ; 4) sequence reads 484 with average quality greater than Q15 over a sliding window of 4 bp were trimmed 485 before the window, assessed for length and removed if less than 75% of the original 486 length; and 5) no ambiguous base pairs were allowed. The taxonomic composition of 487 the microbiomes was established using MetaPhlAn version 2 65 . Normalization using 488
Witten-Bell smoothing was performed since metatranscriptomes are a random sampling 489 of all expressed genes and transcripts can be identified that correspond to genes not 490 represented in the metagenome, particularly for low abundance species that were 491 metabolically active 66 . The relative expression of a gene in a sample was calculated by 492 normalizing the smoothed value of the expression level in the metatranscriptome by the 493 smoothed value of the corresponding gene abundance in the metagenome, as 494 suggested previously 66, 67 . Correlation plots were generated using R corrplot package 495 68 . Genotypic variation of Escherichia coli was performed through reconstructing MLST 496 loci-sequences from metagenomes using metaMLST program 21 . The resulting STs 497 were visualized to show related genotypes of E. coli strains on a minimum spanning 498 tree computed by a goeBURST algorithm 69 implemented in PHYLOViZ 70 . 499
Conclusion 500
At birth there is low abundance of Clostridiales in preterm infants with progressive, 501 significant increase in abundance in the group with rapid progression toward intestinal 502 barrier maturation, but remained low in those with persistent high IP over the first two 503 weeks of life. We further identified neonatal factors previously identified to promote 504 intestinal barrier maturation, including early exclusive breastmilk feeding and shorter 505 duration antibiotic exposure, favor the early colonization of the gut microbiota by 506 members of the Clostridiales, which altogether are associated with improved intestinal 507 barrier function in preterm infants. This highlights the importance of factors such as 508 clinical administration of nutritional supplement and limiting exposure to antibiotic in the 509 high-risk preterm population. Our study suggests rationally selected and formulated 510
Clostridiales species could constitute a promising LBP candidate for the prevention of 511 NEC, especially when combined with already available strains of Bifidobacterium and 512
Lactobacillus. The rationale for this intervention is supported by our correlative finding 513 between increased Clostridiales abundance and intestinal barrier maturation of preterm 514 neonates at-risk for NEC development. Identification of specific strains of Clostridiales, 515 their functions in mediating intestinal barrier maturation, LBP formulation and 516 manufacturing, dosing, safety and efficacy evaluation will be needed to support their 517 application as oral supplementation to promote intestinal barrier maturation and overall 518 health of preterm neonates. Early prediction and prevention of NEC will ultimately 519 improve overall infant survival rates. 520 low IP. The most outstanding difference between high and low IP in preterm infants is in 733
the Clostridiales (p-value = 0.01), which is the most abundant bacterial group in phase 734 II/III infants. MetaPhlAn (55) 
